Pharmaceutical Traceability in Nigeria Explained: A Guide to Nigeria’s Track and Trace Requirements
Pharmaceutical traceability is becoming increasingly important in Nigeria as the country works to improve medicine safety, strengthen supply chain visibility, and reduce the risks associated with substandard and falsified medicines.
For pharmaceutical manufacturers, importers, and distributors, traceability is no longer just an operational consideration. It is also a regulatory priority. The National Agency for Food and Drug Administration and Control (NAFDAC) has introduced a regulatory framework to improve the tracking of pharmaceutical products as they move through the supply chain.
Under this framework, businesses need to understand how pharmaceutical traceability works, what the requirements involve, and how to prepare their operations for implementation.
In this guide, we explain pharmaceutical traceability, explore NAFDAC’s track and trace initiative, outline the applicable compliance timelines, and discuss how businesses can prepare for Nigeria’s evolving traceability requirements.
What Is Pharmaceutical Traceability and Why Does It Matter in Nigeria?
Pharmaceutical traceability is the ability to identify and track a medicine throughout the supply chain, from its point of manufacture or importation to the distributor, pharmacy, healthcare facility, or other authorised destination.
It involves assigning identifiable product information and recording relevant events as medicines move between supply chain participants. These records help establish where a product originated, where it has been, and which organisations handled it along the way.
AfriTrack by AfriHealth is product traceability solution, designed to help pharmaceutical and consumer goods businesses identify products, track their movement across the supply chain, and manage traceability records using GS1 standards.
Why Is Pharmaceutical Traceability Important?
Pharmaceutical traceability supports several important objectives.
- Combating substandard and falsified medicines: Traceability systems help identify suspicious products, verify product information, and support investigations into falsified medicines.
- Improving supply chain visibility: Traceability helps businesses monitor product movements and establish where medicines have travelled across distribution channels.
- Supporting product recalls: Traceability records help businesses identify affected batches and locate products when a recall is necessary.
- Improving inventory management: Traceability helps businesses monitor product movements, reconcile shipments, and identify products approaching their expiry dates.
- Strengthening accountability: Recording product movements helps establish which organisations handled a medicine at different stages of its journey.
In Nigeria, these benefits align with NAFDAC’s broader objective of improving pharmaceutical supply chain security, reducing the risks associated with substandard and falsified medicines, and strengthening patient safety.
Understanding NAFDAC’s Track and Trace Initiative
NAFDAC’s pharmaceutical track and trace initiative is designed to improve visibility into the movement of medicines across Nigeria’s pharmaceutical supply chain.
The initiative builds on Nigeria’s National Pharmaceutical Traceability Strategy, which established a roadmap for implementing traceability using globally recognised GS1 standards. The strategy aims to connect product identification, supply chain records, and information sharing to improve the monitoring of pharmaceutical products.
In October 2024, NAFDAC introduced the Pharmaceutical Products (Traceability) Regulations 2024, providing a formal regulatory framework for tracing drugs and related products manufactured, imported, distributed, sold, or used in Nigeria.
The regulation addresses areas such as product identification, labelling, data carriers, and the capture and sharing of traceability information.
NAFDAC has also developed traceability infrastructure, including its Traceability Information System (TIS) and Scan2Verify mobile application, to support product verification and the recording of relevant supply chain events.
The initiative is intended to provide greater visibility into pharmaceutical products as they move from manufacturers and importers through distribution channels to their final destinations.
How Does Pharmaceutical Traceability Work?
Pharmaceutical traceability connects a product’s identity with records of its movement through the supply chain. Although the technology and workflows can vary between organisations, the process generally involves the following steps.
Step 1: Identify the Product
Each applicable product is assigned a unique identifier. Depending on the requirements, this may combine a product identifier, such as a Global Trade Item Number (GTIN), with a serial number, batch number, and expiry date.
The information can be represented in a suitable data carrier, such as a GS1 DataMatrix barcode, which can be scanned by compatible equipment.
Step 2: Record Product Information
The relevant product information is registered in the traceability system. This may include the product’s name, identification number, manufacturer, batch details, and expiry date.
Accurate product master data is important because it provides the foundation for identifying products consistently throughout the supply chain.
GS1 standards provide a common framework for identifying products, organisations, and locations and for exchanging information about product movements. These standards help different supply chain participants share information consistently, even when they use different business systems.
Step 3: Record Supply Chain Movements
As products move from one location to another, relevant events are captured in the traceability system.
For example, a manufacturer may record a shipment to a distributor, after which the distributor records receipt and subsequent distribution to another location.
These records help establish a history of product movement and custody. Standards such as Electronic Product Code Information Services (EPCIS) support the structured sharing of information about these events.
Step 4: Verify Products and Review Records
When a product is scanned or its identifier is checked through an appropriate verification system, available information can be used to assess its recorded identity and status.
Discrepancies, unexpected product movements, or other suspicious records can be investigated further.
Step 5: Monitor Products and Respond to Issues
Businesses and relevant authorities can use traceability information to investigate supply chain discrepancies, identify affected products, support recalls, and improve oversight.
The effectiveness of this process depends on accurate data, reliable recordkeeping, and participation by the relevant supply chain stakeholders.
NAFDAC Traceability Requirements and Compliance Timelines
NAFDAC’s Pharmaceutical Products (Traceability) Regulations 2024 establish a framework for improving the identification and tracking of pharmaceutical products in Nigeria.
Businesses operating within the pharmaceutical supply chain should understand the requirements that apply to their products and operations and consult the relevant regulatory documents when planning implementation.
What Do the Traceability Requirements Cover?
Key areas addressed by the regulatory framework include:
Unique product identification
Applicable pharmaceutical products must carry unique identifiers assigned in accordance with the regulation. These identifiers support the identification of products as they move through the supply chain.
Product labelling and data carriers
Products must meet applicable labelling requirements, including requirements relating to the data carriers used to represent product identification information.
Product master data
Businesses must manage accurate product information, including the attributes required for traceability. Consistent master data helps ensure that products can be identified correctly across different systems and organisations.
Traceability event records
Relevant supply chain events must be captured in accordance with applicable requirements. These records help establish product movements and support traceability throughout the supply chain.
Information sharing
The framework provides for the capture and sharing of traceability information to support regulatory monitoring and supply chain visibility.
The precise obligations depend on the applicable provisions and implementation directives. Businesses should review the full regulation and relevant NAFDAC guidance rather than relying on a general summary.
What Are the Pharmaceutical Traceability Compliance Deadlines in Nigeria?
GS1 Nigeria’s published pharmaceutical traceability resource lists the following effective compliance dates for different categories of finished pharmaceutical products:
Effective date | Product category |
1 January 2027 | Finished products containing narcotics or controlled substances |
1 January 2028 | Finished maternal, newborn, child health and nutrition (MNCH) products, including antibiotics and antimalarials |
1 January 2029 | All finished pharmaceutical products |
These dates indicate a phased approach to implementing traceability requirements across product categories.
Note: Businesses should confirm the applicable deadlines, product scope, and any subsequent directives through official NAFDAC regulatory resources before making implementation decisions.
NAFDAC Traceability Requirements and Compliance Timelines
Although traceability requirements apply across the pharmaceutical supply chain, the practical steps involved can differ depending on an organisation’s role.
Pharmaceutical Manufacturers
Manufacturers may need to incorporate product serialization into their production and packaging processes, maintain accurate product master data, and ensure that applicable traceability information is captured and shared.
They may also need to assess their existing production systems, labelling equipment, and processes for managing product identifiers.
Pharmaceutical Importers
Importers need to consider how product identification and traceability information will be obtained from overseas manufacturers and maintained as products enter and move through Nigeria’s pharmaceutical supply chain.
Coordination with international suppliers is particularly important where products are manufactured or serialized outside Nigeria.
Pharmaceutical Distributors and Wholesalers
Distributors and wholesalers play an important role in maintaining traceability after products leave the manufacturer or importer.
Their processes may need to support the recording of incoming shipments, product movements, outgoing shipments, and relevant receiving events. Accurate records help maintain visibility as products move between organisations and locations.
Pharmacies and Healthcare Facilities
Pharmacies and healthcare facilities represent important points in the pharmaceutical supply chain. Their ability to receive, verify, and maintain appropriate records of products helps support traceability closer to the point of dispensing or use.
The requirements applicable to each organisation should be assessed against its role, the products it handles, and the relevant regulatory provisions.
How AfriTrack Helps Businesses Prepare for Pharmaceutical Traceability
Preparing for pharmaceutical traceability requires businesses to connect product identification with reliable records of product movement. For organisations managing multiple products, facilities, and distribution partners, doing this manually can become increasingly difficult.
AfriTrack, developed by AfriHealth, is an end-to-end track and trace platform designed to help pharmaceutical and consumer product companies manage product serialization, authentication, and supply chain traceability.
Built around GS1 standards, AfriTrack supports businesses in improving product visibility and managing the data and workflows involved in traceability.
AfriTrack helps businesses prepare for pharmaceutical traceability by enabling them to:
- Manage product serialization: Create and manage unique product identities using information such as GTINs, serial numbers, batch numbers, and expiry dates.
- Record and monitor product movements: Track product movements across participating supply chain locations and monitor shipment progress.
- Manage product aggregation: Link individual products to higher packaging levels, such as cartons and pallets, to support warehouse and distribution workflows.
- Verify products and generate reports: Check product information, review relevant traceability records, and generate traceability reports.
- Generate and report EPCIS events: Structure traceability event information to support the exchange of records across systems.
- Integrate with existing business systems: Connect with systems such as enterprise resource planning (ERP) platforms, warehouse management systems, barcode printers, scanners, and production lines.
Summary
For pharmaceutical manufacturers, importers, and distributors preparing for Nigeria’s traceability requirements, the right technology can help simplify implementation and support more efficient traceability operations.
However, software alone does not guarantee compliance. Businesses must also meet the applicable regulatory requirements, maintain accurate information, and establish the necessary operational processes.
Preparing your business for pharmaceutical traceability in Nigeria?
Frequently Asked Questions About Pharmaceutical Traceability in Nigeria
Pharmaceutical traceability is the ability to identify and track medicines throughout the supply chain using product identifiers and records of relevant events. It helps establish a product’s origin, movement, and supply chain history.
NAFDAC’s track and trace initiative is a programme to improve visibility into pharmaceutical products as they move through Nigeria’s supply chain. It uses product identification, traceability records, and information-sharing systems to support supply chain security and patient safety.
The NAFDAC Pharmaceutical Products (Traceability) Regulations 2024 is a regulatory framework governing the traceability of drugs and related products manufactured, imported, distributed, sold, or used in Nigeria. It addresses product identification, labelling, data carriers, and traceability information.
The published phased compliance dates are 1 January 2027 for finished products containing narcotics or controlled substances, 1 January 2028 for finished MNCH products, including antibiotics and antimalarials, and 1 January 2029 for all finished pharmaceutical products. Businesses should confirm the applicable scope and any subsequent directives with NAFDAC.
Traceability can help identify suspicious products, expose discrepancies in product records, and support investigations into falsified medicines. However, it is not a guarantee that every product is genuine or safe. It works alongside other regulatory, verification, and quality assurance measures.
Businesses should review the applicable regulatory requirements, assess their product and location data, evaluate their labelling and scanning processes, review their existing systems, train relevant employees, and determine how they will capture and share required traceability information.
A traceability solution like AfriTrack that supports relevant GS1 standards and applicable regulatory workflows can help businesses manage these activities more efficiently.